Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release


+1 617 482 1211 (Toll-free 1-800-77-OXFAM)

Press Release

Merck’s Patent Pool Offer Not Enough for Global Access


In response to Merck’s announcement that it has granted a license for its promising COVID-19 pill to the Medicines Patent Pool, Robbie Silverman, Oxfam America’s Senior Manager for Private Sector Engagement, made the following statement:

“Merck’s move to license molnupiravir is welcome as it could indeed mean increased access to its promising COVID-19 drug in the poorest countries in the world. But this agreement still locks out access from a number of middle-income countries around the world, like large parts of Latin America, where millions of the world's poorest people live.

“A corporation should never decide who should live and who should die. Merck’s move is yet another reminder that we need global solutions to a global pandemic. While this step will save lives, many more lives would be saved if Merck would issue a worldwide license for molnupiravir.

“Merck, as well as Pfizer and Moderna, must immediately share their life-saving technologies. It is high time for governments to step up by waiving intellectual property protections and mandating corporations share their technology that the public helped to fund.  We need a comprehensive TRIPS waiver that covers vaccines, therapeutics, and diagnostics as the fastest way to saving the most lives and ending the pandemic as soon as possible.”


Oxfam International is a global movement of people who are fighting inequality to end poverty and injustice. We are working across regions in about 70 countries, with thousands of partners, and allies, supporting communities to build better lives for themselves, grow resilience and protect lives and livelihoods also in times of crisis.

'A No-Brainer': Lawmakers Urge Pelosi to Hold Vote on Stock Trading Ban

"Perhaps this means some of our colleagues will miss out on lucrative investment opportunities," said House members in a bipartisan letter. "We don't care."

Jessica Corbett ·

Advocacy Group Urges Pfizer to Combat Paxlovid Inequality

"Help end the pandemic this year around the world," one advocate told Pfizer. "Not just in a handful of rich countries."

Kenny Stancil ·

260+ Companies Demand 'Big, Bold Action' on Clean Energy

"The time to act is now," the firms wrote in a letter to Chuck Schumer and Nancy Pelosi.

Andrea Germanos ·

Right-Wing Supreme Court Takes Up Challenge to Affirmative Action

"We will vigorously defend access and opportunity in higher education," said head of civil rights legal group.

Jessica Corbett ·

PG&E Should Be Broken Up Over Probation 'Crime Spree': Judge

The utility is emerging from probation this week as "a continuing menace" to Californians, said a federal judge.

Julia Conley ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.

Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo